Nasdaq
SLS
SELLAS Life Sciences Group, Inc.
- Health Care
- 1 day
- −1.3%
- 1 month
- −13.3%
- 1 year
- +636%
$11.70 · Mkt cap $2.18B
At the 6 Aug 2026 close
Nasdaq
SELLAS Life Sciences Group, Inc.
$11.70 · Mkt cap $2.18B
At the 6 Aug 2026 close
SELLAS Life Sciences Group, Inc. trades under the ticker SLS on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $2.18B. The last closing price was $11.70, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +636%, and −13.3% over the past month. Returns are price returns and exclude dividends.
This page exists because SLS is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.